Can doxycycline be used to treat erythrasma?

Doxycycline for Erythrasma: Not First-Line Treatment

While doxycycline has broad antimicrobial activity and is FDA-approved for various bacterial infections, it is not specifically indicated or recommended as first-line therapy for erythrasma. The evidence strongly supports topical fusidic acid or oral clarithromycin/erythromycin as superior treatment options.

Why Doxycycline Is Not Recommended

The FDA label for doxycycline 1 does not list erythrasma among its approved indications, despite extensive coverage of other bacterial infections including rickettsial diseases, chlamydial infections, and various gram-positive and gram-negative organisms. This absence is notable and clinically significant.

More importantly, the most recent systematic review of erythrasma treatments (2025) 2 found that topical fusidic acid provides faster symptom relief, greater reduction in Wood's lamp fluorescence, and fewer side effects compared to other options. For systemic therapy, clarithromycin demonstrated superior efficacy to erythromycin 2.

Evidence-Based Treatment Hierarchy

First-Line Options:

• Topical fusidic acid cream: Most effective with best safety profile 2, 3, 4
  • Applied twice daily for 14 days
  • 87% cure/improvement rate 4
  • Significantly faster resolution than oral antibiotics 3

Second-Line Systemic Options:

• Clarithromycin: Single-dose or short course 3

  • More effective than erythromycin at 48 hours 3
  • Better patient compliance due to shorter duration

• Erythromycin 500mg four times daily for 14 days 4

  • 77% cure/improvement rate 4
  • More gastrointestinal side effects than clarithromycin

Clinical Reasoning

While doxycycline possesses anti-inflammatory properties 5 and broad-spectrum activity against gram-positive organisms including Corynebacterium species 1, no clinical trials have evaluated its efficacy specifically for erythrasma. The comparative studies that established treatment standards for this condition 3, 4 did not include doxycycline in their protocols.

Important Caveats

• Diagnosis confirmation: Always verify with Wood's lamp examination showing coral-red fluorescence before treatment 2, 6
• Duration matters: Erythrasma often goes undiagnosed for months (mean 9-18 months in vulvar cases 6), so ensure adequate treatment duration
• Topical therapy preferred: Better safety profile and efficacy than systemic options 2
• PAS-D staining: If biopsy performed, intracorneal filamentous rods confirm diagnosis 6

Practical Algorithm

1. Confirm diagnosis with Wood's lamp (coral-red fluorescence)
2. Start topical fusidic acid cream twice daily for 14 days
3. If topical therapy fails or extensive disease: Use clarithromycin (single dose or short course) OR erythromycin 500mg QID for 14 days
4. Reassess at 2 weeks: Wood's lamp should show decreased fluorescence
5. Follow-up at 4 weeks to confirm cure

Bottom line: Use fusidic acid topically or clarithromycin/erythromycin systemically—not doxycycline—for erythrasma treatment.